Biotechnological plants generally implement the concepts of biotechnology which is a new and emerging technology. This technology is very powerful and has developed several therapeutic proteins that are also called as biological medicating agents that have the capability to cure several health hazards and completely eliminate them. These restorative proteins are developed from living resources such as plants and animals. These proteins do not have any side-effects.
According to the latest reports, around 130 salutary proteins are currently available in the market and many more are under their developmental stages. Human insulin was the first therapeutic protein developed by the biotechnological plants which was a remarkable achievement in the field of medical science. The discovery of these recombinant proteins changed the face of pharmaceutical engineering.
It earned enormous success due to its development.
These proteins are highly potential and can cure the deadliest diseases. This is used in several treatments and therapies. These proteins have wide range of applications in numerous fields and are able to cure blood clotting disorders, diabetes etc. Various human vaccines have also been produced to provide resistance against viral infections. Due to their great curing capacity against several diseases, they are in high demand.
Theoretically, every living organism can be perceived as the potential source to provide recombinant proteins. But only few sources can be used for the extraction of these beneficial medicines. These proteins can heal a number of diseases. Hence, biotechnological plants are trying hard to extract these important proteins from the plant sources.